[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349509-105":59,"doc-detail-349509-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","proteomic-differentiation-of-colorectal-cancer-from-normal-tissue-via-ex-vivo-e-biopsy-a-novel-approach-to-molecular-sampling-for-diagnostic-precision","Proteomic Differentiation of Colorectal Cancer From Normal Tissue via Ex Vivo E-Biopsy - A Novel Approach to Molecular Sampling for Diagnostic Precision","","Colorectal cancer (CRC) is among the most common malignancies worldwide, and early diagnosis remains a clinical priority. Current biopsy methods are invasive, spatially constrained, and may miss tumor molecular heterogeneity. This study evaluates electroporation-based e-biopsy as a minimally invasive way to collect proteomic samples from CRC tissues ex vivo. In a multicenter, multinational cohort of 19 patients, paired tumor and adjacent normal tissues were processed using electroporation, protein isolation, and LC–MS/MS with bioinformatics to define CRC-specific protein signatures and pathways.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/proteomic-differentiation-of-colorectal-cancer-from-normal-tissue-via-ex-vivo-e-biopsy-a-novel-approach-to-molecular-sampling-for-diagnostic-precision/349509/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/proteomic-differentiation-of-colorectal-cancer-from-normal-tissue-via-ex-vivo-e-biopsy-a-novel-approach-to-molecular-sampling-for-diagnostic-precision/349509.png","ImageObject",300,407,{"name":92,"@type":93},"kopisore","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-16","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main goal of this study?","Question",{"text":112,"@type":113},"To assess the feasibility and diagnostic potential of electroporation-based e-biopsy for proteomic sampling of colorectal cancer tissues.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were samples collected and analyzed?",{"text":117,"@type":113},"Paired tumor and adjacent normal tissues were sampled ex vivo using e-biopsy, then proteins were analyzed by LC–MS/MS with differential expression, PCA, and pathway analyses.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the researchers find about protein recovery and CRC-specific signatures?",{"text":121,"@type":113},"E-biopsy retrieved more proteins from tumor than from adjacent normal tissues, and among 3246 proteins identified, 54% were significantly upregulated in tumor tissues, including candidates such as DLAT, LETM1, RBBP4, PPIB, and BCAP31.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},349509,1790363029,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962090880963,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Cancer Medicine  \n|  RESEARCH ARTICLE  OPEN ACCESS \u003Cbr>Proteomic Differentiation of Colorectal Cancer From Normal Tissue via Ex Vivo E-Biopsy: A Novel Approach to Molecular Sampling for Diagnostic Precision\u003Cbr>Gintautas Saulis1 | Edward Vitkin2 | Rita Saule1 | Julia Wise2 | Antanas Gulbinas3,4 | Žilvinas Dambrauskas3 | Sandra Ivanauskienė3 | Justas Žilinskas5 | Lina Poskiene6 | Alexander Golberg2,7\u003Cbr>1Department of Biology, Vytautas Magnus University, Kaunas, Lithuania | 2School of Mechanical Engineering, Tel Aviv University, Tel Aviv,\u003Cbr>Israel | 3Institute for Digestive Research, Kaunas, Lithuani | 4Faculty of Health Sciences, Klaipeda University, Klaipeda, Lithuania | 5Department of Surgery, Lithuanian University of Health Sciences, Kaunas, Lithuania | 6Department of Pathology, Lithuanian University of Health Sciences, Kaunas, Lithuania | 7Department of Biomedical Engineering, Rutgers, the State University of New Jersey, Piscataway, New Jersey, USA\u003Cbr>Correspondence: Alexander Golberg ([agolberg@tauex.tau.ac.il](agolberg@tauex.tau.ac.il))\u003Cbr>Received: 28 October 2025 | Revised: 27 March 2026 | Accepted: 29 April 2026\u003Cbr>Keywords: biomarker discovery | biomarkers | cancer proteomics | colon | colorectal cancer (CRC) | diagnostics | e-biopsy | electroporation-based biopsy | molecular pathology | non-invasive biopsy |  |\n| --- | --- |\n| ABSTRACT\u003Cbr>Colorectal cancer (CRC) is one of the most common malignancies worldwide. Early and accurate diagnosis remains a clinical priority, yet current biopsy techniques are invasive, spatially limited, and may not capture the molecular heterogeneity of tumors. We evaluated the feasibility and diagnostic potential of electroporation-based biopsy (e-biopsy) as a minimally invasive technique for proteomic sampling of colorectal cancer tissues. We conducted a multicenter, multinational study involving 19 patients undergoing surgical resection for CRC. Paired tumor and adjacent normal tissues were sampled ex vivo using e-biopsy. Proteins extracted from each sample were analyzed via LC–MS/MS. Bioinformatics pipelines, including differential expression, PCA, and pathway analysis, were used to identify CRC-specific signatures. E-biopsy consistently retrieved more proteins from tumor tissues than from adjacent healthy tissues (mean: 1300 vs. 800) . Of the 3246 proteins identified, 54% were significantly upregulated in tumor tissues. Notably, proteins such as DLAT, LETM1, RBBP4, PPIB, and BCAP31 emerged as potential CRC biomarkers. Functional analyses revealed dysregulation in RNA processing, immune response, and metabolic pathways, consistent with known CRC biology. The integrated workflow, spanning tissue collection, electroporation, protein isolation, and mass spectrometry analysis across four institutions in two countries, was successfully executed, demonstrating the feasibility of multi-institutional implementation of the e-biopsy protocol while preserving tissue integrity throughout. E-biopsy enables rapid, reproducible, and minimally invasive molecular sampling of CRC tissue. This study demonstrates its potential to complement standard histopathology, aid in early diagnosis, and support molecularly guided treatment strategies in colorectal oncology. |  |\n| 1 | Introduction | diagnosis are critical for improving patient outcomes, yet cur- |\n| Colorectal cancer (CRC) remains one of the leading causes of cancer-related mortality worldwide. Early detection and accurate | rent diagnostic methods have notable limitations. Colonoscopy, fecal-based tests [1, 2], and imaging techniques such as computed tomography (CT), colonography, and magnetic resonance |\n| Abbreviations: CRC, colorectal cancer; E, V/cm electric field strength; e-biopsy, electroporation-based biopsy; E-biopsy, Electroporation-based biopsy; FDR, false detection rate; LC/MS/MS, liquid chromatography mass spectrometry; NT, normal tissue adjust to tumor; PEF, pulsed electric fields. |  |\n| This is an open access article under the terms","cbCaiq6j7BYrPtmR","https://ap.wps.com/l/cbCaiq6j7BYrPtmR","pdf",1430017,14,"English","# Introduction\n## Study aim and clinical motivation\n# Methods and workflow\n## Tissue sampling with e-biopsy\n## Proteomics and data analysis","[{\"question\":\"What is the main goal of this study?\",\"answer\":\"To assess the feasibility and diagnostic potential of electroporation-based e-biopsy for proteomic sampling of colorectal cancer tissues.\"},{\"question\":\"How were samples collected and analyzed?\",\"answer\":\"Paired tumor and adjacent normal tissues were sampled ex vivo using e-biopsy, then proteins were analyzed by LC–MS/MS with differential expression, PCA, and pathway analyses.\"},{\"question\":\"What did the researchers find about protein recovery and CRC-specific signatures?\",\"answer\":\"E-biopsy retrieved more proteins from tumor than from adjacent normal tissues, and among 3246 proteins identified, 54% were significantly upregulated in tumor tissues, including candidates such as DLAT, LETM1, RBBP4, PPIB, and BCAP31.\"}]","Proteomic Differentiation of Colorectal Cancer From Normal Tissue via Ex Vivo E-Biopsy - A Novel Approach to Molecular Sampling for Diagnostic Precision | PDF",1790084003,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2a62e203161e711fc217bc37ff259737.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8d105e16a676f9da1c03d52c3ce06810.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2285d29e5d3d1caecac104088e665c9f.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bdf490fc150dbc1a404b66b66467af6b.webp",980,1287]